The Pulmonary Hypertension Association’s Scientific Leadership Council, 28 global leaders in the field of pulmonary hypertension, have spearheaded the PHA-Accredited PH Care Centers (PHCC) initiative to establish a program for accreditation of centers with special expertise in pulmonary hypertension (PH), particularly pulmonary arterial hypertension (PAH), to raise the overall quality of care and outcomes in patients with this life-threatening disease.
Why Accreditation is Needed
Once considered rapidly fatal, PAH can now be treated with many medications, all developed in just the past two decades. Despite medical advances, the median time from onset of symptoms to PAH diagnosis is still 1.1 years, and many patients will see three or more different physicians over this period before they are properly diagnosed. Since early 2011, PHA’s Scientific Leadership Council has developed the PHCC initiative to assure outstanding care in pulmonary hypertension.
More Information
The PHA-Accredited PH Care Centers (PHCC) program is an initiative of PHA’s Scientific Leadership Council to accredit centers in the U.S. in order to raise the level of care for individuals with pulmonary hypertension (PH). Accreditation is based on a center’s overall commitment to PH patients, breadth of involved health care professionals and scope of services provided.
How to Find a PH Specialist In the PHCC Network
PHA has created a map to assist in locating a PHCC near you.
Map of accredited PH care centers
PH specialists in the PHCC network also can be found in our Doctors Who Treat PH directory. They will be designated as part of an accredited PH program in your search.
How PH Care Centers Are Expected to Improve Your Medical Care
- Patients are better informed about comprehensive PH care
- Patients have improved access to Centers with expertise in PH
- Patients experience less time between symptom onset and diagnosis
- A medical community better informed about standards of PH care
- Therapies are appropriately used to improve long-term outcomes
- Increased opportunities for collaboration between Centers for clinical care and PH research
The Two Types of Centers
Two types of centers are accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Both accredited CCCs and RCPs will have demonstrated a commitment to providing expert-level care based on pulmonary arterial hypertension (PAH) consensus guidelines.
Centers of Comprehensive Care
A PHA-Accredited Center of Comprehensive Care is a highly organized, full-time PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of pulmonary arterial hypertension (PAH) patients with all of the FDA-approved therapies. CCCs also make important contributions to PH research and education.
Regional Clinical Programs
A PHA-Accredited Regional Clinical Program is a regional PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of PAH patients with all non-parenteral therapies. An RCP must collaborate with its regional CCCs by referring patients that may benefit from opportunities unavailable at the RCP, including the initiation of advanced parenteral therapies and participation in clinical research protocols.
Developing and Implementing the PHCC Program
In September 2011, members of the PHA Board of Trustees, the PHA Scientific Leadership Council, and other key stakeholders in the PH community approved the PHCC initiative in concept. A steering committee and task forces were organized and staffed to address accreditation criteria, program implementation, registry development, communication to key stakeholders and financial sustainability. The members below provided valuable contributions, which include: researching, accumulating and documenting information, developing logic models, defining action steps, building financial projections and validating the program content.
| Murali Chakinala, MD (PHCC Chair) | Washington University in Saint Louis |
| Rino Aldrighetti | PHA |
| Richard Channick, MD | Harvard Medical School |
| C. Gregory Elliott, MD | University of Utah |
| Serpil Erzurum, MD | The Cleveland Clinic Foundation |
| Karen Fagan, MD | University of South Alabama |
| Bob Gray | PHA |
| Michael Patrick Gray, MPH | PHA |
| Carl Hicks | PHA |
| Wendy Hill, RN, MSN | VA Greater LA Healthcare System |
| Steven Kawut, MD, MS (Patient Registry Task Force Chair) | University of Pennsylvania |
| Vallerie McLaughlin, MD | University of Michigan |
| Stephen Mathai, MD, MHS | Johns Hopkins University |
| Olivia Onyeador, MHA | PHA |
| Ron Oudiz, MD (Criteria Task Force Chair) | Harbor UCLA Medical Center |
| Abby Poms, RRT, RCP (Implementation Task Force Co-Chair) | Duke University |
| Jeffrey Sager, MD, MSCE | Cottage Hospital |
| Robert Schilz, DO, PhD | Case Western Reserve University |
| Traci Stewart, RN, MSN | University of Iowa |
| Darren Taichman, MD | University of Pennsylvania |
| Victor Tapson, MD | Cedars-Sinai |
| Corey Ventetuolo, MD, MS | Brown University |
| Joel Wirth, MD (Implementation Task Force Co-Chair) | Maine Medical Center |
| Roham Zamanian, MD (Funding Task Force Chair) | Stanford University |
PHCC Initiative Mission Statement
The purpose of the PHA-Accredited Pulmonary Hypertension Care Centers (PHCC) initiative is to establish a program of accredited centers with expertise in pulmonary hypertension that aspires to improve overall quality of care and ultimately improve outcomes of patients with pulmonary hypertension, particularly pulmonary arterial hypertension, a rare and life-threatening group of diseases.
Why the Need for Accreditation?
Despite the availability and success of PAH-targeted therapeutic options over the past two decades, there are still shortcomings with the diagnosis and management of PAH. One recent study observed that expert recommended diagnostic algorithms were not being followed to completion in up to 94% of PAH patients, and nearly 60% of PAH referrals to expert centers already on therapy were on so contrary to published guidelines. In addition, despite the available medical therapies, long-term outcomes are still not optimal as many patients still die from PH, require transplantation or require hospitalization.
PH Care Centers: What You Need to Know
Two types of centers are be accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Please note that applications for Pediatric Regional Clinical Programs are not currently being accepted. Learn more about the PH Care Centers initiative:
- Application Process
- Accreditation Criteria
- Frequently Asked Questions
- Informational Webinars
- PHCC Medical Leadership
- Get Involved
PHCC News and Research
Advisory: Reproductive Health and Pulmonary Hypertension
Pregnancy is considered high risk for people with pulmonary hypertension because their heart and lungs can’t easily adjust to the demands of pregnancy and childbirth.
CEO Update: Find New Inspiration for Patient Care at PHPN Symposium
Registration opens Friday for the Pulmonary Hypertension Association (PHA) PH Professional Network Symposium. If you’re a doctor, nurse or other health care professional who cares for people with pulmonary hypertension, sign up to learn the latest science about PH. Your patients will be the ultimate beneficiaries of your attendance. Learn more about this invaluable opportunity, set for Sept. 28-30 in Arlington, Virginia.
How Expiring Pandemic Measures Will Affect Health Care Benefits
Federal measures implemented at the beginning of the COVID-19 pandemic are expected to end in May. That means many people won’t be eligible for health care benefits they received during the pandemic.. Discover how Medicaid and Medicare coverage will be affected. Learn more.
Join Us in San Diego for Our Next Free PH Community Workshop
If you live on the West Coast, join us May 6 in San Diego for the Pulmonary Hypertension Association (PHA)’s first free regional workshop under a new name. The events previously known as PHA on the Road are now called PHA PH Community Workshops. The next event will be July 29 in the Boston area.
How Do You Cope With PH? Join a Support Group for Connections and Resources
Estella Medina couldn’t do much physically when she was diagnosed with pulmonary hypertension. She depended on her husband, children, parents and sister for help at home. The family’s assistance was critical at a time when Estella’s disease was difficult to manage. But she found something equally beneficial to help her cope: Pulmonary Hypertension Association support groups.
Join PHA for Multi-Year Membership Discounts
Pulmonary Hypertension Association (PHA) members have a new way to manage their membership dues – and get discounted rates. PHA is now offering multi-year membership enrollment, which means you can sign up for several years at once. The more years you enroll, the greater your discount will be.
Researchers: Apply for PHA Research Grants
The Pulmonary Hypertension Association (PHA) encourages pulmonary hypertension professionals to apply for two research grants. They are: Early Career Mentored Scientist Award ($65,000 for one year) and Innovation Research Award ($60,000 a year for two years).
How Can the Inflation Reduction Act Help You?
The Inflation Reduction Act provides cost-relief benefits to people with Medicare plans. Learn when changes will go into effect and how you might benefit from the law.
Tampa Walk Raises $20K for PHA
The pulmonary hypertension community raised more than $20,000 in the fifth annual Tampa O2breathe Walk and 5K. The Feb. 18 event was held in memory of Missy Stok Rizzo, who died in 2018.
Decreasing Lung Pressure Gives Hope a Year After Diagnosis
Uraiwan Campbell went to urgent care for what she thought was an infected scratch on her leg. But after several days in the hospital and many tests, she learned her swollen leg was related to pulmonary hypertension. A recent heart catheterization showed her lung pressure has declined, buoying her spirits.
Symposium to Feature Session on Mental Health and Wellness
The Pulmonary Hypertension Association (PHA)'s PH Professional Network (PHPN) Symposium will include a session on wellness and mental health for pulmonary hypertension (PH) providers and patients. The event is Sept. 28-30 in Arlington, Virginia. Registration opens this month.
Get Help Resolving Specialty Pharmacy Challenges
If you have prescription refill, billing or other challenges related to your specialty pharmacy, the Pulmonary Hypertension Association (PHA) can connect you to the right people.
Support Group Leader Advisory Board Names New Member
The Pulmonary Hypertension Association (PHA) welcomes Doug Taylor to its Support Group Leader Advisory Board. Doug, who was diagnosed in 2003, has led the Midlands-Columbia group in South Carolina for 16 years. Doug is known for celebrating each day. “If we make each day a holiday and celebrate, it makes our life fuller,” Doug says.
Houston PH Community Raises $19K for PHA
Rain didn’t stop the Houston-area pulmonary hypertension (PH) community from raising more than $19,000 at its first O2breathe walk. The Jan. 28 at Buffalo Bayou Partnership Water Works-Brown Foundation celebrated participants, patients and top fundraisers.
Was AmazonSmile Your Preferred Way to Support PHA? Try this alternative
Amazon is ending its AmazonSmile donation program, which many Pulmonary Hypertension Association (PHA) supporters took part in. If you'd like to continue supporting PHA programs through everyday purchases, consider using our new "round-up" feature for online giving.
Cincinnati PH Specialist Receives Pediatric Research Award
Paul Critser, M.D., Ph.D., has received the Pulmonary Hypertension Association Pediatric PH Research Award.
PHA Names 2022 PHA Pediatric Research Awardee
The Pulmonary Hypertension Association (PHA) is pleased to announce Paul Crister, M.D., Ph.D., as the recipient of the 2022 Pediatric PH Research Award. The research award supports research that could have a great impact toward advancing the field of PH pediatrics.
Pump Life is Tough. But Family, Friends and Hot Sauce Help Patient Stay Positive
Chloe Merritt, 22, is still getting used to a low-sodium diet, lack of energy and the challenges of a subcutaneous pump after her September 2022 diagnosis. But the life-changing experience has brought her closer than ever to family and friends. And it led her to a new favorite food. Chloe shares her positive outlook in the Right Heart Blog.